US2909462A
(en)
|
1955-12-08 |
1959-10-20 |
Bristol Myers Co |
Acrylic acid polymer laxative compositions
|
US3783098A
(en)
|
1971-08-10 |
1974-01-01 |
Cornell Res Foundation Inc |
Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
|
US3915794A
(en)
|
1973-02-09 |
1975-10-28 |
Rit Rech Ind Therapeut |
Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
|
US4000256A
(en)
|
1975-04-30 |
1976-12-28 |
Merck & Co., Inc. |
Varicella vaccine and process for its preparation
|
US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
US4431739A
(en)
|
1979-11-05 |
1984-02-14 |
Genentech, Inc. |
Transformant bacterial culture capable of expressing heterologous protein
|
US4425437A
(en)
|
1979-11-05 |
1984-01-10 |
Genentech, Inc. |
Microbial polypeptide expression vehicle
|
US4338397A
(en)
|
1980-04-11 |
1982-07-06 |
President And Fellows Of Harvard College |
Mature protein synthesis
|
US4769331A
(en)
|
1981-09-16 |
1988-09-06 |
University Patents, Inc. |
Recombinant methods and materials
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
US4745051A
(en)
|
1983-05-27 |
1988-05-17 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
IL84154A0
(en)
|
1986-10-16 |
1988-03-31 |
Microgenesys Inc |
Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
WO1990001543A1
(fr)
|
1988-07-29 |
1990-02-22 |
Intracel Corporation |
Procede d'expression genetique de proteines heterologues par des cellules transfectees in vivo
|
CA2003300A1
(en)
|
1988-11-21 |
1990-05-21 |
Franklin Volvovitz |
Skin test and test kit for aids
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5552143A
(en)
|
1989-03-24 |
1996-09-03 |
The Wistar Institute Of Anatomy & Biology |
Recombinant cytomegalovirus vaccine
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
US5178862A
(en)
|
1989-12-01 |
1993-01-12 |
Parhelion Corporation |
Canine distemper virus vaccine and method of preparation
|
AT395893B
(de)
|
1990-01-10 |
1993-03-25 |
Mayreder Kraus & Co Ing |
Befestigungsvorrichtung zum verbinden von bauteilen
|
GB9001766D0
(en)
|
1990-01-25 |
1990-03-28 |
Univ Court Of The University O |
Vaccines
|
US5514375A
(en)
|
1990-08-15 |
1996-05-07 |
Virogenetics Corporation |
Flavivirus recombinant poxvirus vaccine
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
AU650045B2
(en)
*
|
1990-09-12 |
1994-06-09 |
Lifecell Corporation |
Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
KR100242671B1
(ko)
|
1991-03-07 |
2000-03-02 |
고돈 에릭 |
유전학적으로 처리한 백신 균주
|
US5843456A
(en)
|
1991-03-07 |
1998-12-01 |
Virogenetics Corporation |
Alvac poxvirus-rabies compositions and combination compositions and uses
|
US5846805A
(en)
|
1991-08-26 |
1998-12-08 |
Boehringer Ingelheim Animal Health, Inc. |
Culture of swine infertility and respiratory syndrome virus in simian cells
|
US5382425A
(en)
|
1992-01-13 |
1995-01-17 |
Syntro Corporation |
Recombinant swinepox virus
|
US5338543A
(en)
|
1992-02-27 |
1994-08-16 |
Ambico, Inc. |
Thimerosal inactivated mycoplasma hyopneumoniae vaccine
|
US5695766A
(en)
|
1992-10-30 |
1997-12-09 |
Iowa State University Research Foundation |
Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
|
AU681874B2
(en)
|
1993-02-08 |
1997-09-11 |
Bayer Corporation |
Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
|
US5846945A
(en)
|
1993-02-16 |
1998-12-08 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
US6485729B1
(en)
|
1993-09-13 |
2002-11-26 |
Protein Sciences Corporation |
Neuraminidase-supplemented compositions
|
FR2723740B1
(fr)
|
1994-08-16 |
1996-11-08 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
|
FR2728795B1
(fr)
|
1994-12-30 |
1997-03-21 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
|
WO1996029096A1
(fr)
|
1995-03-17 |
1996-09-26 |
Hisamitsu Pharmaceutical Co., Inc. |
Preparation de transfert genique
|
EP0826063A1
(en)
|
1995-04-25 |
1998-03-04 |
Vical Incorporated |
Single-vial formulations of dna/lipid complexes
|
JPH08333277A
(ja)
|
1995-06-05 |
1996-12-17 |
Hoechst Japan Ltd |
ヒト血液凝固第xiii因子の安定化された水性液製剤
|
FR2741806B1
(fr)
|
1995-11-30 |
1998-02-20 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
|
FR2742756B1
(fr)
|
1995-12-22 |
1998-04-03 |
Pasteur Merieux Serums Vacc |
Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
|
US5866401A
(en)
|
1996-03-01 |
1999-02-02 |
Schering Corporation |
Porcine reproductive and respiratory syndrome vaccine
|
US6509146B1
(en)
*
|
1996-05-29 |
2003-01-21 |
Universal Preservation Technologies, Inc. |
Scalable long-term shelf preservation of sensitive biological solutions and suspensions
|
AU3214597A
(en)
*
|
1996-05-29 |
1998-01-05 |
Universal Preservation Technologies, Inc. |
Long-term shelf preservation by vitrification
|
FR2750866B1
(fr)
|
1996-06-27 |
1998-11-27 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
|
FR2750865B1
(fr)
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
WO1998000166A1
(en)
|
1996-07-03 |
1998-01-08 |
Merial, Inc. |
Recombinant canine adenovirus (cav) containing exogenous dna
|
US6090393A
(en)
|
1996-07-03 |
2000-07-18 |
Merial |
Recombinant canine adenoviruses, method for making and uses thereof
|
FR2751223B1
(fr)
|
1996-07-19 |
1998-12-04 |
Rhone Merieux |
Formule de vaccin polynucleotidique felin
|
FR2751227B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
|
FR2751224B1
(fr)
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
|
FR2751229B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
|
FR2751226B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique contre les pathologies du cheval
|
FR2751228B1
(fr)
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Vaccin polynucleotidique bovin pour voie intradermique
|
FR2751225B1
(fr)
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique aviaire
|
US6403098B1
(en)
|
1996-09-26 |
2002-06-11 |
Merck & Co., Inc. |
Rotavirus vaccine formulations
|
CN1195863C
(zh)
|
1996-10-17 |
2005-04-06 |
牛津生物医学(英国)有限公司 |
逆转录病毒载体
|
FR2757061B1
(fr)
|
1996-12-16 |
1999-03-26 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
|
US6290967B1
(en)
|
1996-12-20 |
2001-09-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized vaccines
|
US6051238A
(en)
|
1996-12-20 |
2000-04-18 |
Merck & Co., Inc. |
Stabilizers for lyophilized mumps vaccines
|
FR2758986B1
(fr)
|
1997-01-31 |
1999-04-30 |
Rhone Merieux |
Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
|
US6183752B1
(en)
|
1997-02-05 |
2001-02-06 |
Pasteur Merieux Serums Et Vaccins |
Restenosis/atherosclerosis diagnosis, prophylaxis and therapy
|
US6368603B1
(en)
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
US6004777A
(en)
|
1997-03-12 |
1999-12-21 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
US5990091A
(en)
|
1997-03-12 |
1999-11-23 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
KR20010022863A
(ko)
|
1997-08-13 |
2001-03-26 |
피터 브이. 오`네일 |
유전자 벡터의 국소 적용에 의한 백신접종
|
US6391314B1
(en)
|
1997-10-03 |
2002-05-21 |
Merial |
Porcine circoviruses vaccines diagnostic reagents
|
FR2781159B1
(fr)
|
1998-07-06 |
2000-10-06 |
Merial Sas |
Vaccin circovirus et parvovirus porcin
|
EP0913177A1
(de)
*
|
1997-11-03 |
1999-05-06 |
Roche Diagnostics GmbH |
Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
|
US6224882B1
(en)
|
1997-11-07 |
2001-05-01 |
Protein Science Corp. |
Insect cells or fractions as adjuvant for antigens
|
FR2775601B1
(fr)
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
ATE350486T1
(de)
|
1998-05-15 |
2007-01-15 |
Quark Biotech Inc |
Durch mechanischen stress induzierte gene, deren expressionsprodukte und deren verwendung.
|
US6103526A
(en)
|
1998-10-08 |
2000-08-15 |
Protein Sciences Corporation |
Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
|
TWI224107B
(en)
|
1998-10-22 |
2004-11-21 |
Pfizer Prod Inc |
Novel proteins from actinobacillus pleuropneumoniae
|
US6017537A
(en)
|
1998-12-18 |
2000-01-25 |
Connaught Laboratories, Inc. |
Formyl methionyl peptide vaccine adjuvant
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
FR2796397B1
(fr)
|
1999-07-16 |
2006-09-01 |
Merial Sas |
Genes de calicivirus felin et vaccins notamment vaccins recombines
|
US6541001B1
(en)
*
|
1999-08-24 |
2003-04-01 |
Teva Pharmaceutical Industries, Ltd. |
Vaccine composition and method of using the same
|
US6872357B1
(en)
*
|
2000-11-22 |
2005-03-29 |
Quadrant Drug Delivery Limited |
Formulation of preservation mixtures containing sensitive biologicals to be stabilized for ambient temperature storage by drying
|
US20030064000A1
(en)
*
|
2001-09-24 |
2003-04-03 |
Wilson Burgess |
Methods of sterilizing biological mixtures using stabilizer mixtures
|
WO2003092377A1
(en)
*
|
2002-05-01 |
2003-11-13 |
Cryoglass Llc |
Cryopreservation system for liquid substances
|
AU2004299057B2
(en)
|
2003-12-17 |
2010-06-24 |
Wyeth Llc |
Methods for porducing storage stable viruses and immunogenic compositions thereof
|
US20060141483A1
(en)
|
2004-12-23 |
2006-06-29 |
Calton Gary J |
Stabilization of viral compositions
|
US7956160B2
(en)
*
|
2005-07-22 |
2011-06-07 |
Amgen Inc. |
Concentrated protein lyophilates, methods, and uses
|
GB0517688D0
(en)
*
|
2005-08-31 |
2005-10-05 |
Cambridge Biostability Ltd |
Improvements in the stabilisation of biological materials
|
WO2007035455A2
(en)
|
2005-09-16 |
2007-03-29 |
Merial Limited |
Stabilizers for freeze-dried vaccines
|
US20090155351A1
(en)
|
2005-10-04 |
2009-06-18 |
Alk-Abello A/S |
Solid Vaccine Formulation
|
EP2851087B1
(en)
*
|
2006-11-07 |
2017-04-19 |
Sanofi Pasteur Biologics, LLC |
Stabilization of vaccines by lyophilization
|
EP2143440A1
(fr)
|
2008-07-09 |
2010-01-13 |
Sanofi Pasteur |
Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
|
CA2783715A1
(en)
*
|
2009-12-29 |
2011-07-07 |
F. Hoffmann-La Roche Ag |
Novel antibody formulation
|
US20120222979A1
(en)
*
|
2011-03-04 |
2012-09-06 |
Elwha LLC, a limited liability company of the State of Delaware |
Glassy compositions
|
US11696302B2
(en)
|
2018-09-10 |
2023-07-04 |
Ntt Docomo, Inc. |
User terminal
|